Skip to content
Open access

Network and experimental pharmacology to decode the antihyperglycemic action of selected ethnobotanicals

Sep 2026 · Journal of Integrative and Translational Biomedicine · Vol 1, pp. 104-121 · 0 citations · 6 references

TL;DR

Combined extract of these ethnobotanicals effectively reduced hyperglycemia by restoring glucose homeostasis by restoring glucose homeostasis and established notable antidiabetic effects of selected ethnobotanicals through improved glucose homeostasis, inhibition of α-amylase and α-glucosidase enzymes, and ameliorated metabolic abnormalities via multi-target mechanisms.

Abstract

Background: Curcuma longa, Emblica officinalis, Momordica charantia, Pterocarpus marsupium, Salacia chinensis, and Tinospora cordifolia are ethnobotanicals with antidiabetic properties. Nevertheless, the effect of these plants when used together against diabetes is unestablished. Therefore, this study investigates the combined action of above-mentioned medicinal plants using network and experimental pharmacology. Methods: In network pharmacology module, compound of all six plants were evaluated for drug-likeness, and their corresponding targets were identified and subjected to enrichment analysis. Additional experiment was conducted using a high-fat diet, low-dose streptozotocin-induced diabetic model. Furthermore, in vitro α-amylase and α-glucosidase enzyme inhibition assays were performed. Results: Among all compounds evaluated, (S)-tembetarine from E. officinalis showed highest drug-likeness score of 1.2. Likewise, enrichment analysis of identified targets revealed distinct cellular components, biological processes, and molecular functions. Molecular docking further showed that Lobatoside I from M. charantia exhibited strongest binding affinity toward α-amylase, with a docking score of -15.587, while (−)-(3S)-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-(6E)-6-hepten-3-ol from C. longa showed strongest binding affinity toward α-glucosidase, with a score of -9.284. Subsequent experimental pharmacology demonstrated that combined extract of these ethnobotanicals effectively reduced hyperglycemia by restoring glucose homeostasis, as confirmed by oral glucose tolerance test and insulin tolerance test. Combined extract also improved lipid metabolism and glycogenesis. Moreover, α-amylase and α-glucosidase enzymes were inhibited by extract in concentration-dependent. Bodyweight showed a gradual increase alongside a reduction in food intake. Additionally, after 18 days of treatment, there was decline in nitrogen metabolites, ameliorated lipid profile, and hepatic glycogen content. Conclusion: This study established notable antidiabetic effects of selected ethnobotanicals through improved glucose homeostasis, inhibition of α-amylase and α-glucosidase enzymes, and amelioration of metabolic abnormalities via multi-target mechanisms.

Read PDF

Similar papers

Review Open access Sep 2026

Phytochemistry and Pharmacology of Baiyaozi (Stephania cephalantha): A Review

Baiyaozi is the dried tuber of Stephania cepharantha, a plant belonging to the genus Stephania in the family Menispermaceae, and is a traditional Chinese medicine. This study conducted a systematic review of relevant literature from databases such as PubMed and Web of Science to discuss the structural characteristics a...

Jin-Shuo Ma, Nai-Bei Hou, Ying-Ying Wang et al. · 0 citations
Open access Sep 2026

Cryptotanshinone and 15,16-dihydrotanshinone I from Salvia miltiorrhiza: integrated in vitro and computational evaluation of their antidiabetic potential

Overall, compound 2 exhibited the stronger experimentally measured yeast α-glucosidase inhibition, whereas the computational findings provide target-specific hypotheses rather than confirming multitarget antidiabetic activity.

M. C. Nguyen, Minh-Tri Le, Huynh Nguyen Khanh Tran · 0 citations
Review Open access Sep 2026

Multitarget Pharmacological Mechanisms and Safety Profiles of Six Ethnobotanically Prioritized Indonesian Medicinal Plants for Cardiometabolic Disorders: A Systematic Review

Abstract This systematic review, conducted per PRISMA guidelines, examined the pharmacological activities and safety of six ethnobotanically prioritized medicinal plants for cardiometabolic disease: Gynura procumbens, Mimosa pudica, Tithonia diversifolia, Leucaena leucocephala, Smallanthus sonchifolius, and Syzygium cu...

F. A. Saputri, R. M. Febriyanti, Zulfan Zazuli et al. · 0 citations
Review Open access

Botany, phytochemistry and pharmacology of Heracleum candicans: A review

Heracleum candicans, a perennial herb of the Heracleum genus in the Umbelliferae family, is naturally distributed in Pakistan, northwestern India, as well as Sichuan and Xizang of China. In the Xizang region, its dried roots have long been utilized as a traditional Tibetan medicine. Ethnopharmacologically, it possesses...

Yunfeng Bai, Juan Li, Shouzhu Xu et al. · 0 citations
Open access Aug 2026

Integrated network pharmacology and in vitro/in silico evaluation of the bioactive potential of Gundelia komagenensis fırat extracts

Network pharmacology suggested that the identified phenolics may regulate disease-related pathways through AP-1/NF-κB-associated targets and chlorogenic acid emerged as a key multi-target candidate warranting further experimental validation.

Abdülmelik Aras, Yunus Dağhan, Alpaslan Bayrakdar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.